CAS: 163105-89-3; (6-Methoxypyridin-3-yl)Boronic Acid

相似化合物

445264-61-9 612845-44-0 870521-30-5

上下游产品

CAS号13472-85-0 5-溴-2-甲氧基吡啶 | CAS号121-43-7 硼酸三甲酯 | CAS号5419-55-6 硼酸三异丙酯 | CAS号624-28-2 2,5-二溴吡啶 | CAS号380917-97-5 吡仑帕奈 | CAS号381233-78-9 5-(2-吡啶基)-1,2-二... | CAS号51834-97-0 5-羟基-2-甲氧基吡啶 | CAS号1015481-14-7 3-甲氧基-6-(6-甲氧基-... | CAS号15871-85-9 6-甲氧基-3-吡啶甲腈 | CAS号53698-47-8 2-甲氧基-5-苯基吡啶 | CAS号381248-06-2 3-溴-1-苯基-5-(吡啶-... | CAS号381725-49-1 6'-甲氧基-2,3'-联吡啶

2-甲氧基吡啶置于n-溴代丁二酰亚胺(Nbs),正丁基锂体系中,用 四氢呋喃,乙腈 用作溶剂,化学反应 22.0H,反应生成2-甲氧基-5-吡啶硼酸
参考文献: Combination Therapy With A Phosphoinositide 3-Kinase Inhibitor With A Zinc Binding Moiety[fr] Polythérapie Avec Un Inhibiteur De Phosphoinositide 3-Kinase Avec Une Fraction De Liaison Au Zinc
标题: Combination Therapy With A Phosphoinositide 3-Kinase Inhibitor With A Zinc Binding Moiety[fr] Polythérapie Avec Un Inhibiteur De Phosphoinositide 3-Kinase Avec Une Fraction De Liaison Au Zinc
摘要:该发明提供了一种治疗癌症的方法,包括向需要的受试者施用:(A) 公式i的化合物或其药学上可接受的盐,其中r为氢或酰基;和(B) Bcl-2抑制剂;其中公式i的化合物或其药学上可接受的盐和bcl-2抑制剂以联合治疗有效的剂量进行施用.该发明还提供了一种包括公式i的化合物或其药学上可接受的盐,Bcl-2抑制剂和药学上可接受的载体或赋形剂的药物组合物.

专利信息

专利号:US-8742118-B2
优先权日:2011-10-27
标题 :Methods for preparing intermediates of perampanel
发明人：FONTANA FRANCESCO; STABILE PAOLO
权利人:F I S —FABBRICA ITALIANA SINT S P A
摘要:Methods for the synthesis of 2-alkoxy-5-(pyridin-2-yl)pyridine of formula I n nor salts thereof are provided.

专利号:US-8207337-B2
优先权日:2007-01-29
标 题:Reagent for organic synthesis reaction containing organic triol borate salt
发明人：MIYAURA NORIO; YAMAMOTO YASUNORI
权利人:MIYAURA NORIO; YAMAMOTO YASUNORI; WAKO PURE CHEM IND LTD
摘要:[Problem] n To provide an organoboron compound-containing reagent for organic synthesis reactions which undergoes no trimerization with dehydration, does not necessitate activation with a base, and is stable and highly active. n [Means for Solving Problems] n The reagent for organic synthesis reactions contains an organic triol borate salt represented by any of the general formulae (I) to (III) and general formula (XVI): (wherein R 1 represents alkyl, alkenyl, etc.; R 2 represents optionally substituted alkyl, alkenyl, alkynyl, etc. or represents hydrogen; m + represents an alkaline metal ion, phosphonium ion, or given ammonium ion; M 2+ represents an alkaline earth metal; X represents halogen or alkoxide; Y represents an alkali metal ion, etc.; A represents optionally substituted methylene; and n represents an integer).

专利号:WO-2006079916-A1
优先权日:2005-01-26
标 题 :Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
发明人：ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
权利人:PHARMACIA & UPJOHN CO LLC; ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I): wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:US-2021070762-A1
优先权日:2018-06-29
标 题 :Synthesis of coelenterazine

专利号:US-2024239803-A1
优先权日:2018-06-29
标题 :Synthesis of coelenterazine

专利号:US-2007275968-A1
优先权日:2004-09-07
标 题 :Substituted Biphenyl Derivative
发明人：KURATA HITOSHI; NISHIMATA TOYOKI; WATANABE YUKIKO; EBISAWA MASAYUKI; FUJIMOTO TEPPEI; KOBAYASHI HIDEKI
权利人:KURATA HITOSHI; NISHIMATA TOYOKI; WATANABE YUKIKO; EBISAWA MASAYUKI; FUJIMOTO TEPPEI; KOBAYASHI HIDEKI
摘要:The present invention relates to a biaryl derivative or a pharmacologically acceptable salt thereof having an excellent collagen-synthesis inhibition activity. A biaryl derivative having a structure represented by the following General Formula (I) or a pharmacologically acceptable salt thereof: n nwherein n R 1 represents a C 6 -C 10 aryl group which is substituted with one to three group(s) each independently selected from the group consisting of a group defined by formula R-L-, a di-(C 1 -C 6 alkyl)amino group, a di-(C 1 -C 6 alkyl)aminosulfonyl group, a hydroxyaminocarbonyl group, and a halogen atom, and so on; R represents a C 1 -C 6 alkyl group, and so on; L represents a sulfonyl group, an aminosulfonyl group, or a sulfonylamino group, and so on; R 2 represents a hydrogen atom, and so on; A represents a group defined by formula (II), (III), or (IV); R 3 represents a C 1 -C 6 alkyl group, and so on; and R 4 represents a C 1 -C 6 alkyl group, and so on.